Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study
Guardado en:
Autores principales: | Mehmet Serdar Küçükoğlu, İsmail Hanta, Bahri Akdeniz, Sümeyye Güllülü, Ersan Atahan, Tamer Sayın, Gülfer Okumuş, Zeynep Pınar Önen, Mehmet Yokuşoğlu, Arzu Baygül |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KARE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/117c1f8116b64743b37c78b178f17e00 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hyperbaric Oxygen Therapy with Iloprost Improves Digit Salvage in Severe Frostbite Compared to Iloprost Alone
por: Marie-Anne Magnan, et al.
Publicado: (2021) -
Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries
por: Jain PP, et al.
Publicado: (2014) -
Resting heart rate and real-life treatment modalities in outpatients with left ventricular systolic dysfunction study: A multicenter, prospective, observational, and national registry
por: Yüksel Çavuşoğlu1, et al.
Publicado: (2021) -
Tratamiento crónico combinado con iloprost y sildenafil en un paciente con hipertensión pulmonar primaria
por: Isa P,Rodrigo, et al.
Publicado: (2004) - Inhalation toxicology